NO883200L - Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt. - Google Patents

Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt.

Info

Publication number: NO883200L
Authority: NO; Norway
Prior art keywords: intranasal administration; salt; cholinergagonist; galle; pharmaceutical preparation
Prior art date: 1987-07-30

Application number

NO88883200A

Other languages

English (en)

Other versions

NO883200D0 (no

Inventor

Franklin M Boghen

Franco Camanni

Piero Del Soldato

Ezio Ghigo

Eugenio E Muller

Original Assignee

Pierrel Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-30

Filing date

1988-07-19

Publication date

1989-01-31

1988-07-19 Application filed by Pierrel Spa filed Critical Pierrel Spa

1988-07-19 Publication of NO883200D0 publication Critical patent/NO883200D0/no

1989-01-31 Publication of NO883200L publication Critical patent/NO883200L/no

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
102100022831 Somatoliberin Human genes 0.000 abstract 1
101710142969 Somatoliberin Proteins 0.000 abstract 1
239000003833 bile salt Substances 0.000 abstract 1
239000000064 cholinergic agonist Substances 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
208000037824 growth disorder Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO88883200A 1987-07-30 1988-07-19 Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt. NO883200L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT21513/87A IT1222395B (it)	1987-07-30	1987-07-30	Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare

Publications (2)

Publication Number	Publication Date
NO883200D0 NO883200D0 (no)	1988-07-19
NO883200L true NO883200L (no)	1989-01-31

Family

ID=11182925

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO88883200A NO883200L (no)	1987-07-30	1988-07-19	Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt.

Country Status (12)

Country	Link
US (1)	US5010056A (no)
EP (1)	EP0301392B1 (no)
JP (1)	JPS6450823A (no)
KR (1)	KR890001584A (no)
AT (1)	ATE76753T1 (no)
AU (1)	AU618547B2 (no)
DK (1)	DK393188A (no)
IT (1)	IT1222395B (no)
NO (1)	NO883200L (no)
NZ (1)	NZ225546A (no)
PH (1)	PH26712A (no)
ZA (1)	ZA885417B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0383931A (ja) *	1989-08-29	1991-04-09	Sumitomo Pharmaceut Co Ltd	低刺激性ｇｒｆ経鼻投与製剤
EP0432431B1 (en) *	1989-11-16	1993-06-16	PHIDEA S.p.A.	Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
US5502067A (en) *	1994-02-04	1996-03-26	Morgan; Julia A.	Treating apneahypopnea/snoring in humans
US5500205A (en) *	1994-02-23	1996-03-19	Enviro Pac International, L.I.C.	Lachrymator aerosol formulations
US5861431A (en) *	1995-06-07	1999-01-19	Iotek, Inc.	Incontinence treatment
AUPN801296A0 (en)	1996-02-12	1996-03-07	Csl Limited	Stabilised growth hormone formulation and method of preparation thereof
US8048875B1 (en)	1997-02-24	2011-11-01	S.L.A. Pharma Ag	Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
CN1127333C (zh) *	1997-02-24	2003-11-12	S.L.A.药业股份公司	含有胆碱能药物或钙通道阻滞剂的局部用医药组合物
ATE289825T1 (de) *	1999-04-21	2005-03-15	1355540 Ontario Inc	Methacoline oder histamine formulierungen zur feststellung von asthma
JP2005505491A (ja) *	1999-06-02	2005-02-24	ヘキサル・アクチェンゲゼルシャフト	水溶性活性物質の鼻腔内投与用医薬組成物
WO2001041732A1 (en) *	1999-12-06	2001-06-14	Gore Stanley L	Compositions and methods for intranasal delivery of active agents to the brain
JP3498041B2 (ja)	2000-05-29	2004-02-16	科研製薬株式会社	プラルモレリン含有点鼻用製剤
US8299079B2 (en) *	2009-05-22	2012-10-30	Kaufman Herbert E	Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) *	2009-05-22	2010-11-25	Kaufman Herbert E	Preparations and Methods for Ameliorating or Reducing Presbyopia
EP3027637B1 (en) *	2013-08-01	2019-10-09	The U.S.A. As Represented By The Secretary, Department Of Health And Human Services	The glycine conjugate of beta-muricholic acid as an inhibitor of the farnesoid x receptor for the treatment of obesity, insulin resistance or non-alcoholic fatty liver disease
EP4203958A4 (en) *	2020-08-26	2024-10-09	Oticara, Inc.	COMPOSITIONS, DEVICES AND METHODS FOR TREATING NOSE, EAR AND OTHER TISSUE INFECTIONS AND/OR INFECTIONS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ206518A (en) *	1982-12-10	1989-06-28	Syntex Inc	Nasal composition comprising nona- or deca-peptide lhrh analogue and bile acid surfactant
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
IT1169873B (it) *	1983-10-21	1987-06-03	Prodotti Formenti Srl	Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
US4818531A (en) *	1985-02-06	1989-04-04	Eli Lilly And Company	Growth hormone and thyroid hormone
JPS62126135A (ja) *	1985-11-25	1987-06-08	Sumitomo Pharmaceut Co Ltd	経鼻投与用ｇｒｆ製剤
US4663318A (en) *	1986-01-15	1987-05-05	Bonnie Davis	Method of treating Alzheimer's disease
US4880778A (en) *	1986-05-12	1989-11-14	Eastman Kodak Company	Combinations having synergistic growth hormone releasing activity and methods for use thereof

1987
- 1987-07-30 IT IT21513/87A patent/IT1222395B/it active
1988
- 1988-07-14 DK DK393188A patent/DK393188A/da not_active Application Discontinuation
- 1988-07-19 NO NO88883200A patent/NO883200L/no unknown
- 1988-07-20 EP EP88111657A patent/EP0301392B1/en not_active Expired - Lifetime
- 1988-07-20 AT AT88111657T patent/ATE76753T1/de active
- 1988-07-21 PH PH37251A patent/PH26712A/en unknown
- 1988-07-25 NZ NZ225546A patent/NZ225546A/en unknown
- 1988-07-25 ZA ZA885417A patent/ZA885417B/xx unknown
- 1988-07-25 US US07/223,378 patent/US5010056A/en not_active Expired - Fee Related
- 1988-07-26 AU AU20051/88A patent/AU618547B2/en not_active Ceased
- 1988-07-27 KR KR1019880009436A patent/KR890001584A/ko not_active Withdrawn
- 1988-07-28 JP JP63187052A patent/JPS6450823A/ja active Pending

Also Published As

Publication number	Publication date
ATE76753T1 (de)	1992-06-15
EP0301392A1 (en)	1989-02-01
DK393188D0 (da)	1988-07-14
AU2005188A (en)	1989-02-02
NZ225546A (en)	1990-12-21
EP0301392B1 (en)	1992-06-03
NO883200D0 (no)	1988-07-19
KR890001584A (ko)	1989-03-27
AU618547B2 (en)	1992-01-02
DK393188A (da)	1989-01-31
IT8721513A0 (it)	1987-07-30
IT1222395B (it)	1990-09-05
ZA885417B (en)	1989-06-28
PH26712A (en)	1992-09-15
JPS6450823A (en)	1989-02-27
US5010056A (en)	1991-04-23

Similar Documents

Publication	Publication Date	Title
NO883200D0 (no)	1988-07-19	Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt.
DK0496796T3 (da)	1994-10-03	Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelse
FI875645A0 (fi)	1987-12-21	Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten
IT1218548B (it)	1990-04-19	Perno autofilettante per l'impianto di protesi dentali
NO884625D0 (no)	1988-10-18	N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel.
OA08214A (en)	1987-10-30	Apparatus and methodology for pulsed administration of growth promoting agents.
EP0242643A3 (en)	1988-04-06	Nasal administration of drugs
NO885797L (no)	1989-06-30	Karboksylsyrederivater med terapeutisk virkning og fremgangsmaate til deres fremstilling.
DK128688A (da)	1988-09-13	Thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
ITMI911791A1 (it)	1992-12-28	Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
DK164441C (da)	1992-11-09	Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
NO880434D0 (no)	1988-02-01	Anestetisk preparat og fremgangsmaate for bruk derav.
DK122391D0 (da)	1991-06-21	Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO167734C (no)	1991-12-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
MY103210A (en)	1993-05-29	Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NO874850D0 (no)	1987-11-20	Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DK567188A (da)	1989-04-13	2,2-dimethylchromenderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK598288D0 (da)	1988-10-27	Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen
DK134990D0 (da)	1990-05-31	Praeparat til tandbehandling samt fremgangsmaade til fremstilling deraf
DK325289D0 (da)	1989-06-29	Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
EP0355612A3 (en)	1990-08-22	New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
DK221288A (da)	1988-10-24	2beta-,16beta-diamino-androstaner og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende en saadan forbindelse
NO870834D0 (no)	1987-02-27	Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
DK0486586T3 (da)	1994-10-24	Kynurensyrederivater, fremstilling deraf og farmaceutiske præparater, der indeholder dem
NO881554L (no)	1988-10-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-((1,1-difenyl)-1-alkenyl)piperazin-derivater og farmasoeytisk aksepterbare salter av disse derivater.